Patent Expiry
Patent/Exclusivity Expiry: ZEJULA
- Drug
- ZEJULA
Other upcoming events for ZNTL
Phase 2 ReadoutPhase 2 Readout: azenosertib
Phase 2 ReadoutPhase 2 Readout: azenosertib
Phase 2 ReadoutPhase 2 Readout: azenosertib
Phase 2 ReadoutPhase 2 Readout: azenosertib
Phase 3 ReadoutPhase 3 Topline: A Randomized, Open-Label Phase 3 Study of Azenosertib Versus Investigator's Choice of Chemotherapy i
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.